We are live on
!
Find out more
DMK
David M. Knott Portfolio holdings
AUM
$275M
1-Year Est. Return
59.23%
This Fund
S&P 500
This Quarter
Est. Return
+5.8%
1 Year Est. Return
+59.23%
3 Year Est. Return
+80.95%
5 Year Est. Return
+223.18%
10 Year Est. Return
–
AUM
$243M
AUM Growth
-$8.83M
(-3.5%)
Cap. Flow
-$21M
Cap. Flow
% of AUM
-8.67%
Top 10 Holdings %
Top 10 Hldgs %
68.56%
Holding
127
New
18
Increased
18
Reduced
12
Closed
20
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Calumet Specialty Products
CLMT
|
+$6.99M |
| 2 |
FTAI Aviation
FTAI
|
+$4.2M |
| 3 |
Upland Software
UPLD
|
+$4.19M |
| 4 |
Smith & Wesson
SWBI
|
+$3.62M |
| 5 |
Meta Platforms (Facebook)
META
|
+$3.59M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ligand Pharmaceuticals
LGND
|
+$33.3M |
| 2 |
Pfizer
PFE
|
+$12.4M |
| 3 |
Microsoft
MSFT
|
+$6.16M |
| 4 |
RXDX
Ignyta, Inc.
RXDX
|
+$1.81M |
| 5 |
AVDL
Avadel Pharmaceuticals
AVDL
|
+$1.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 55.53% |
| 2 | Technology | 8.11% |
| 3 | Industrials | 7.13% |
| 4 | Financials | 7.01% |
| 5 | Energy | 6.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Ligand Pharmaceuticals
LGND
$5.59B
| $91.3M | 37.65% |
886,525
-336,474
| -28% | -$33.3M |
|
|
2
Pfizer
PFE
$159B
| $20.9M | 8.63% |
621,940
-361,733
| -37% | -$12.4M |
|
|
3
Upland Software
UPLD
$13.9M
| $10.1M | 4.15% |
35,000
+17,000
| +94% | +$4.19M |
|
4
Capitol Federal Financial
CFFN
$1.07B
| $8.53M | 3.51% |
690,400
| – | – |
|
|
5
FTAI Aviation
FTAI
$20B
| $7.99M | 3.29% |
586,746
+284,745
| +94% | +$4.2M |
|
|
MIC
6
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
| $6.73M | 2.78% |
182,300
+50,000
| +38% | +$2.69M |
|
|
7
Calumet Specialty Products
CLMT
$4.2B
| $6.67M | 2.75% |
+945,558
| New | +$6.99M |
|
8
AbbVie
ABBV
$451B
| $4.97M | 2.05% |
52,500
| – | – |
|
|
APC
9
DELISTED
Anadarko Petroleum
APC
| $4.88M | 2.01% |
80,760
| – | – |
|
10
Apple
AAPL
$4.67T
| $4.2M | 1.73% |
100,200
| – | – |
|
11
Iridium Communications
IRDM
$4.94B
| $3.8M | 1.57% |
338,000
| – | – |
|
|
12
Smith & Wesson
SWBI
$573M
| $3.41M | 1.4% |
+429,330
| New | +$3.62M |
|
13
Howard Hughes
HHH
$3.87B
| $3.24M | 1.34% |
24,442
+3,462
| +17% | +$424K |
|
|
14
Meta Platforms (Facebook)
META
$1.47T
| $3.2M | 1.32% |
+20,000
| New | +$3.59M |
|
15
Delta Air Lines
DAL
$52.7B
| $3.15M | 1.3% |
57,500
| – | – |
|
16
Newell Brands
NWL
$2.63B
| $2.55M | 1.05% |
+100,000
| New | +$2.83M |
|
17
JPMorgan Chase
JPM
$951B
| $2.54M | 1.05% |
23,050
| – | – |
|
18
MPLX
MPLX
$60.1B
| $2.48M | 1.02% |
+75,000
| New | +$2.69M |
|
19
DuPont de Nemours
DD
$18.5B
| $2.4M | 0.99% |
14,865
| – | – |
|
|
MITL
20
DELISTED
Mitel Networks Corporation
MITL
| $2.32M | 0.96% |
+250,000
| New | +$2.19M |
|
21
Oracle
ORCL
$435B
| $2.29M | 0.94% |
+50,000
| New | +$2.49M |
|
|
OSG
22
Octave Specialty Group
OSG
$209M
| $2.28M | 0.94% |
145,426
| – | – |
|
23
Lowe's Companies
LOW
$117B
| $2.19M | 0.9% |
+25,000
| New | +$2.37M |
|
|
CHCT
24
Community Healthcare Trust
CHCT
$428M
| $1.54M | 0.64% |
60,000
| – | – |
|
25
CoreCivic
CXW
$3.34B
| $1.46M | 0.6% |
75,000
| – | – |
|
Similar funds
FA
KCP
HCIA
ISG
TPCM
DCM
MCL
DVC
David M. Knott's Q1 2018 Portfolio in Review
As of Q1 2018, David M. Knott held 127 positions worth $243M, down 3.5% from $251M the previous quarter. Its ten largest holdings account for 69% of the portfolio.
David M. Knott withdrew a net $21M in Q1 2018, closing 20 positions and reducing 12 holdings. Its most notable exit was Ignyta, Inc., an estimated $1.81M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 56% of assets, down from 65% a quarter earlier, followed by Technology and Industrials.
Against the trend, David M. Knott opened a new position in Calumet Specialty Products worth $6.67M.
- David M. Knott's largest Q1 2018 buy was Calumet Specialty Products: 945,558 shares worth $6.67M.
- David M. Knott added most to FTAI Aviation in Q1 2018, an estimated $4.2M increase.
- David M. Knott's biggest Q1 2018 reduction was Ligand Pharmaceuticals, cutting an estimated $33.3M.
- David M. Knott fully exited Ignyta, Inc. in Q1 2018, selling an estimated $1.81M.
- David M. Knott's ten largest holdings make up 69% of its $243M portfolio in Q1 2018.
- David M. Knott opened 18 new positions and closed 20 in Q1 2018.
- David M. Knott's portfolio value fell 3.5% quarter-over-quarter to $243M.
Based on David M. Knott's 13F filing for Q1 2018, filed 11 May 2018.